CIK 0001567264 · <br>Emerging growth company
INTENSITY THERAPEUTICS, INC.
Sign in to watch- Ticker
- INTS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461488089
- Phone
- 203-221-7381
- Business address
- 1 ENTERPRISE DRIVE, SUITE 430, SHELTON, CT, 06484
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-02 | BENDER LEWIS H President and CEO | Grant or award · Stock Option (right to buy Common Stock) | +700,000 | 700,000 | ||
| 2025-05-02 | Talamo Joseph Chief Financial Officer | Grant or award · Stock Option (right to buy Common Stock) | +300,000 | 300,000 | ||
| 2024-10-21 | Wesolowski John M Principal Accounting Officer | Grant or award · Stock Option (right to buy Common Stock) | +70,028 | 70,028 | ||
| 2024-10-21 | Talamo Joseph Chief Financial Officer | Grant or award · Stock Option (right to buy Common Stock) | +427,379 | 427,379 | ||
| 2024-06-05 | Wesolowski John M Principal Accounting Officer | Option exercise | +1,000 | $4.00 | $4K | 6,691 |
| 2024-06-05 | Wesolowski John M Principal Accounting Officer | Option exercise · Stock Option (right to buy Common Stock) | −1,000 | 14,000 | ||
| 2024-05-14 | DUBIN THOMAS I H Director | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 | ||
| 2024-03-06 | Wesolowski John M See Remarks | Grant or award · Stock Option (right to buy Common Stock) | +25,000 | 25,000 | ||
| 2024-03-06 | Leahy Emer Director | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 | ||
| 2024-03-06 | GOLDBERG MARK A Director | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 | ||
| 2024-03-06 | Donovan Daniel Director | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 | ||
| 2024-03-06 | BENDER LEWIS H President and CEO | Grant or award · Stock Option (right to buy Common Stock) | +464,805 | 464,805 | ||
| 2024-03-06 | BENDER LEWIS H President and CEO | Grant or award · Stock Option (right to buy Common Stock) | +33,574 | 33,574 | ||
| 2023-12-11 | Talamo Joseph Chief Financial Officer | Grant or award · Stock Option (right to buy Common Stock) | +80,000 | 80,000 | ||
| 2023-07-19 | Wesolowski John M Interim CFO | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 |
Page 2 of 2 · 35 trades